Immucise

FDA 510(k) K190427 · Terumo Corporation

Substantially Equivalent

510(k) numberK190427

Submission

Device name
Immucise
Applicant
Terumo Corporation
Shibuya-Ku, JP
Received
February 22, 2019
Decision date
July 18, 2019
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
FMF – Syringe, Piston
Device class
Class II (moderate risk)
Regulation
21 CFR 880.5860
Specialty
General Hospital

Other 510(k)s with product code FMF

510(k)DeviceApplicantDecision
K262581GraftGun Universal Graft Delivery System (GDS®)FMF · Special SurGenTec, LLC08/26/2026SE
K252184SOL-M Luer Lock Syringe with Exchangeable Needle TrayFMF · Traditional Sol-Millennium Medical, Inc.08/25/2026SE
K253747Disposable Pen Injector (KXYC-03C02, KXYC-03A03)FMF · Traditional Jiangsu Enjosim Medical Technology Co., Ltd.08/14/2026SE
K260208Ultra-Fine™ SAFETY Insulin SyringeFMF · Traditional embecta Medical II, LLC07/13/2026SE
K253110Sol-Glide Safety Needle; Sol-Glide Safety Needle with SyringeFMF · Traditional Sol-Millennium Medical, Inc.06/18/2026SE
K260514Profoject™ Safety Needle; Profoject™ Syringe with Safety Needle; Profoject™ Low Dead…FMF · Traditional CMT Health PTE., Ltd.06/12/2026SE
K253112Sofjec (Single use Needle); Sofjec (Single use Syringe with or without Needle); Sofjec…FMF · Special Hlb Lifescience Co., Ltd.05/21/2026SE
K252279Sterile Hypodermic Syringe for Single Use (20ml, 30ml, 50ml, 60ml)FMF · Traditional Chirana T.Injecta,A.S.04/17/2026SE
K253068Profoject™ Insulin Syringes; Profoject™ Safelock Disposable Insulin SyringeFMF · Traditional CMT Health PTE., Ltd.02/23/2026SE
K253769Instylla Delivery KitFMF · Special Instylla, Inc.12/22/2025SE

More from Instylla, Inc.

510(k)DeviceDecision
K252295RyureiLOX · Traditional 03/27/2026SE
K250700Pen Injector Needle 32.5FMI · Traditional 11/21/2025SE
K250751DualView CatheterDQO · Traditional 07/17/2025SE
K240818R2P Radifocus Glidewire AdvantageDQX · Traditional 11/26/2024SE
K240859Glidewire GT-RDQX · Traditional 08/21/2024SE
K181369Immucise Intradermal Injection SystemFMI · Traditional 11/13/2018SE
K173799NaviCross 0.018DQY · Traditional 03/29/2018SE
K170417Glidewire GTDQX · Traditional 09/15/2017SE
K130493Capiox RX05 Hollow Fiber Oxygenator/ReservoirDTZ · Special 03/13/2013SE
K130280Capiox FX Hollow Fiber Oxygenator W/ ReservoirDTZ · Special 03/13/2013SE

Questions and answers

When was Immucise cleared by the FDA?

Immucise (K190427) received a 510(k) decision of Substantially Equivalent on July 18, 2019, 146 days after the submission was received.

What is the product code of K190427?

The FDA product code is FMF – Syringe, Piston, a Class II (moderate risk) device regulated under 21 CFR 880.5860.